Sage upgrades online journal platform

Share this article:
Sage upgrades online journal platform
Sage upgrades online journal platform

Sage, an international publisher of medical journals, books and electronic media, is shifting all of its 560-plus titles onto a new platform hosted by Stanford University Libraries' HighWire Press.

All of Sage's journals had a digital site prior to the transition, but the new platform will offer additional features and functionality for readers, and more online advertising real estate for marketers, according to Bob Vrooman, commercial sales director at Sage. Advertising sizes on the HighWire platform are larger, and conform to Internet Advertising Bureau standards. Ad placements include a leader board and a wide skyscraper, said Vrooman.

Sage opted to keep ads out of the PDF versions of its journal articles, to “provide the best online reading experience” for subscribers, and because pharmaceutical drug ads – with their characteristically long, opposite page safety information – can be “a little tricky” to present within a PDF, said Vrooman.      

Although Sage is experimenting with all-digital journals – World Society for Pediatric and Congenital Heart Surgery launched in April as an online-only title – Vrooman said Sage's primary model is still print and digital. “We have a few new journals slated for [online-only] launches, but the model is still new to us, and is in the experimental stage,” said Vrooman.

In 2009, Sage converted approximately 12 journals from print to online-only, but most of those were not medical journals, according to Vrooman. While most of Sage's subscribers outside of the medical division are libraries (rather than individuals), medical journals still attract individual physician subscribers, and “most MDs want the print option,” said Vrooman. “Typically, journals that still attract print advertisers, we'll keep [in print].” Medical journals that did go online-only in 2009 were smaller-profile titles, he said.

In terms of journal advertising revenue, Vrooman said online is slowly increasing, but “until the tipping point happens,” the company will continue to launch journals in print.  

Select titles were transitioned to the new platform ahead of time in order to present the new offering, and can be seen on the journals' homepages. Those titles include Genes & Cancer, Veterinary Pathology, Aesthetic Surgery Journal, and Psychological Science, among others.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...